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Abstract 
 
Captopril has a short biological half life 2-3 hours and has been used for long-term treatment 
of hypertension. The properties of captopril such as absorbed well in the stomach, freely 
water-soluble, instability in intestinal environment, and bioavailability about 65%. This study 
aimed to determine the physical characteristics and drug release profile of captopril tablet 
sustained release with floating system using a cross-linked matrix of alginate with calcium 
chloride as a crosslinker. Matrix system was obtained by forming alginat cross-linked with a 
calcium chloride. HPMC K4M was used to help cross-linked reaction. Tablet was prepared 
by wet granulation with varying levels of sodium alginate and calcium chloride. Dissolution 
test is carried out by paddle method in HCl pH 1,2; 100 rpm; and 37±0,5
o
C for 8 hours. 
Amount of captopril released determined by measuring the captopril dissolved using UV 
spectrophotometry at λ 205 nm. The result showed that this tablet having physical 
characteristics suitable with the general requirements for tablets. Drug release profile of 
captopril tablet sustained release with floating system using a cross-linked matrix of alginate 
with calcium chloride as a crosslinker capable keeping release of captopril up to 8 hours 
(third formula) about 51,226% (DE) and followed zero order kinetics.  
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Introduction 
Drugs with a high frequency of use can 
cause problems such as fluctuations in drug 
concentration in the blood and the patients 
are often less regular using drugs that can 
affect the therapeutic process (Shargel, 
2005). Captopril has a half-life 2-3 hours 
making it suitable for slow-release tablet are 
prepared. Development of slow-release 
captopril tablets will provide some benefit to 
patients who need to take this drug on an 
ongoing in a long time. Some of these 
advantages include increased patient 
compliance in treatment, reducing the 
frequency of drug administration, and reduce 
fluctuations in blood concentrations of drugs 
that reduce the risk of side effects. Captopril 
have properties well absorbed in the 
stomach, easily soluble in water, easily 
oxidized in the intestinal pH, and the 
bioavailability less than the maximum that 
should be considered the development 
strategy of slow-release captopril tablets are 
strong enough to hold the release of the drug 
and can survive in the stomach in a long time 
(Seta et al, 1988). Captopril is passivley 
absorbed in the stomach and the proximal 
small intestine and partly absorbed with the 
help of the peptide, while more than 40% 
eliminated via urine in the form of intact 
(Nur et al, 2000).  
Dosage form that can be retained in the 
stomach called gastroretentive drug delivery 
system (GRDDS). GRDDS can improve 
control of drug delivery is well absorbed in 
the stomach. Residence time in the stomach 
can be improved by: mucoadhesive delivery 
system attached to the mucosal surface, 
delivery systems that can increase the size of 
the drug so it retained because it can not pass 
through the pylorus, and delivery systems to 
control the density so that it can float 
(floating) in gastric fluid (Gohel et al, 2004). 
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According to Arora (Arora et al, 2005) 
one of the method to extend the residence 
time of tablets in the stomach is floating 
system and the system is considered as one 
method of effective and applied in dealing 
with bioavailability. Drugs in the floating 
system is released slowly at a speed that can 
be determined and reduced fluctuations in 
plasma drug concentrations (Chawla et al, 
2003). Floating system can be achieved by 
lowering the dosage so that the density is 
smaller than the density of liquid gastric 
(Zou et al, 2008). Carrier that can be used is 
a polymer which has a density of light that 
can also affect the release of drug from the 
dosage (Garg and Gupta, 2008). Polymers 
used in the floating system is quite diverse, 
there's even a few modifications. One of 
polymer modification in the floating system 
is a cross-link (Kroschwitz et al, 1992).  
Cross-links is a bond of a polymer chain 
with other polymer chains that form the three 
dimensional structure as a result of chemical 
reactions. In cross-link alginate with calcium 
chloride, a calcium ion will replace two 
sodium  ions in the alginate to form a cross-
link. This cross-link structure causes the 
molecular motion is limited and obstructed 
the swelling of polymer in a particular 
medium, so it should be able to improve the 
drug release profile of the preparation 
(Kroschwitz et al, 1992). Cross-link reaction 
of sodium alginate with calcium chloride in 
low pH produce calcium alginate are not 
soluble in water and insoluble in pH 1.2. In 
the acidic conditions in the stomach, the 
swelling of calcium alginate gel is rare, the 
drug will most likely be released by diffusion 
through the insoluble matrix (Tønnesen and 
Karlsen, 2002). 
Based on the description, it is necessary to 
develope captopril in slow-release dosage 
forms with a floating system using alginate 
cross-link matrix with calcium chloride as a 
crosslinker, which is expected to release the 
drug at a controlled rate and stay in the 
stomach for a long time to improve the 
bioavailability. 
 
 
Methods 
Materials.Captopril, HPMC K4M, Ac-di-
Sol, talc (obtained from PT Kimia Farma), 
sodium alginate, calcium chloride, 
magnesium stearate, distilled water, HCl 
0.01 N. 
Methods. Manufacture of slow-release 
tablet dosage forms. Slow-release tablet 
captopril floating system using alginate 
cross-link matrix prepared according to a 
formula that can be seen in Table 1. The 
granules prepared by the method wet 
granulation. Preparation of granules by wet 
granulation method is done by swelling a 
sodium alginate using distilled water to form 
alginate gel and can be flowed. Sodium 
alginate has been swelled which is weighed 
according to the formula and then mixed 
with captopril until homogeneous (mixture 
1). Avicel PH102 was mixed homogeneously 
with 1/5 ac-di-sol (mixture 2). HPMC K4M, 
calcium chloride, and 3/5 ac-in-sol was 
mixed until homogeneous (mixture 3). 
Mixture 1 and mixture 2 mixed until 
completely homogeneous (mixture 4), then 
added a few drops of distilled water until it 
forms a mass of tablets. Mixture of 3 and 4 
blended until completely homogeneous to 
form granules or inner phase in the mass of 
tablets. The granules are sieved using 16 
mesh sieve and then dried in an oven at 50°C 
(dry). Dry granules sieved again with 18 
mesh sieve, then add 1/5 ac-di-sol, talc and 
magnesium stearate sequentially and mixed 
until homogeneous. Mass obtained is then 
compressed into tablets. 
 
Table 1.  Formula slow release captopril tablet 
floating system 
Component F1 F2 F3 F4 F5 
Kaptopril (mg) 
Natrium alginat (%) 
Kalsium klorida (%) 
HPMC K4M (%) 
Ac-di-sol (%) 
Avicel PH102 (%) 
Mg Stearat (%) 
Talk (%) 
Total (mg) 
25 
6 
9 
57 
5 
20 
1 
2 
200 
25 
8 
7 
57 
5 
20 
1 
2 
200 
25 
10 
5 
57 
5 
20 
1 
2 
200 
25 
12 
3 
57 
5 
20 
1 
2 
200 
25 
14 
1 
57 
5 
20 
1 
2 
200 
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Flow properties of granule test. Flow 
properties of granules test performed by the 
method of baring angle and the flow time. 
a. Angle of repose  
The measurement is carried out by 
inserting the granules into a flow meter at 
a height of free-standing on graph paper 
on a horizontal set. The flow meter cover 
is opened so that the granules out and 
accommodated on a plane. (R) is the 
radius of the base of the conical pile and 
(h) is a cone-shaped stack height. Repose 
angle of the granules can be calculated 
by the equation: 
      
 
 
              
 
  
 
Description:  = angle of repose  
 
 
h = height of pile 
  r = radius of pile of granules 
or ½ d (Voight, 1995). 
b. Flow time 
Flow time test carried out by weighing 
100 grams of granules, inserted into the 
flow meter/funnel the stem end is closed. 
Funnel lid is opened and the granules are 
allowed to flow until the end, calculated 
flow time of granules
11
. Granules are said 
to be good when the flow rate has a 10 
g/sec or about 100 grams of granules can 
flow out of the funnel in less than 10 
seconds (Lieberman et al, 1989). 
Evaluation of tablets 
a. Physical Appearance 
Tests carried out by organoleptis physical 
appearance, including examination of the 
uniformity of color, presence or absence 
of odor, surface shape, and presence or 
absence of defects (damage) physical 
(Banker and Anderson, 1986). 
b. Uniformity of size 
Diameter and thickness of the tablet was 
measured by using a long slide and then 
analyzed according to the requirements 
of uniformity in the size of the tablet in 
the Pharmacopoeia. Otherwise stated, the 
diameter of the tablet not more than three 
times and not less than one-third times 
the thick tablet (Anonymous, 1979). 
c. Uniformity of weight 
Up to 20 tablets that have been cleaned 
of dust were weighed individually and 
average weight was calculated, then 
matched with the percentage deviation of 
the weight table in Indonesian 
Pharmacopoeia. Should not exceed 2 
tablets, each of which weighs deviate 
from the mean weight is greater than the 
price specified in column A. Besides, no 
one else tablet weight deviates from the 
average weight of more than the price set 
column B (Anonymous, 1979). 
d. Hardness test 
One tablet is placed in the middle and 
perpendicular to the hardness tester, first 
scale the zero position, then slowly 
rotated the tool to break tablets. Read the 
scale achieved when broken or crushed 
tablets. In general, a good tablet has a 
hardness between 4-10 kg (Anonymous, 
1995). 
e. Friability test 
A total of 20 tablets that have been 
cleaned weighed, then put in friabilator. 
The tool is run 4 minutes, or 100 times a 
round. Tablets were taken and cleaned of 
particles attached to the tablet, weighed 
again, calculated the percentage 
difference in weight or shrinkage. The 
total weight of the tested tablets should 
not be reduced by more than 1% of initial 
weight test. Friability equation is as 
follows: 
    
       
  
        
f. Floating test 
Observation of swelling behaviour and 
floating done visually, the way: the tablet 
is inserted in 100 mL beaker glass 
contained HCl solution pH 1.2. Swelling 
behaviour and the floating observed for 5 
hours. Good results were swelled and 
floating more than 5 hours (Arora et al, 
2005). 
g. Drug release test 
i. Determination of the maximum 
wavelength 
ii. Determined with make the curve 
correlation between the absorbance 
with the wavelength of the captopril 
standard solution at a certain 
concentration
16
. Using the 
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wavelength range between 197-250 
nm (maximum wavelength of 
captopril by USP 29 is 205 nm). 
Wavelength used is the wavelength 
are having of maximum absorbance. 
iii. Preparation of captopril standard 
curve  
iv. Captopril standard curve obtained by 
making a series of captopril solution 
in HCl medium at pH 1.2, the 
concentration is 0.008;  0.010;  0.012;  
0.014;  0.016 mg/ mL. Absorbance of 
each concentration was measured by 
UV-vis spectrophotometer at a 
wavelength of maximum. 
Absorbance data obtained and 
graphed against the concentration to 
obtain the regression equation and 
curve (Gandjar and Rohman, 2007). 
v. Testing of drug release 
vi. Drug release test were performed 
using the method of dissolution 
testing. Dissolution testing performed 
using a type 2 (paddle) at agitation 
speed of 100 rpm in HCl medium pH 
1.2 as much as 900 mL at 37 ± 0.5°C 
for 8 hours. As many as 5 mL aliquot 
was taken at minute 5, 10, 15, 30, 45, 
60, 120, 180, 240, 300, 360, 420, and 
480. Amount of captopril released 
determined by measuring the 
captopril dissolved using UV 
spectrophotometry at a maximum 
wavelength. Furthermore the amount 
of captopril released can be 
calculated using regression equations 
derived from standard curves of 
captopril (Wadher et al, 2011). 
 
Data Analysis. Analysis of the physical 
properties of the drug and drug released from 
tablet using statistical analysis one way 
ANOVA at 95% confidence level. To 
determine the kinetics and mechanism of 
drug release from tablet carried out by 
comparing the value of the regression 
coefficient based on the zero-order kinetics 
equation, first order, and Higuchi equation. 
 
 
Results and Discussion 
The flow properties of granule showed 
baring angle and the flow time are qualified. 
Analysis of baring angle with one way 
ANOVA showed significance (0.078) > 0.05 
it was explained that baring angle of granule 
between the formula not differ significantly. 
The results of the analysis of flow time by 
one way ANOVA showed significance 
(0.01) < 0.05. Then tested LSD, obtained that 
only the formula 5 is significantly different 
than the other formulas. 
The test of repose angle and flow time 
describe the flow properties of granule when 
the tabletting process is running. Flow 
properties of granule is very important 
because it affects the uniformity of the 
compression and tablet weight uniformity 
(Lieberman et al, 1989). Granules or 
powders that have a repose angle of less than 
or equal to 30° usually indicate that the 
material can flow freely, if the angle is 
greater than or equal to 40° the flow is less 
well (Lachman et al, 1994). The size of the 
baring angle influenced by the shape, size, 
granules moisture, gravity and friction forces 
inter-particle, if the tensile force and friction 
forces is small it will be faster and easier 
flow. The flatter the resulting cone, baring 
angle gets smaller and the faster the flow 
properties of powders [11, 13]. 
Based on the formula 1 to formula 5, the 
increased contents of sodium alginate and 
reduced calcium chloride result a more rapid 
flow time. More rapid flow time on formula 
5, this happens because the granules in the 
formula 5 has a relatively larger size. Larger 
granules in the formula 5 is possible because 
of the granules mass during granulation 
relatively more humid because there is 
residual sodium alginate are not bound by 
the crosslinker is calcium chloride, sodium 
alginate is carrying water, causing the mass 
becomes more humid as sodium alginate has 
a hydrophilic properties (Brunetti and 
Martin, 2006) and the granulation process 
forming granules with a size larger. 
According to Lieberman (Lieberman et al, 
1989), large granules will have a small inter-
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granules contact so that the resulting flow 
time was faster. 
The test of physical appearance showed 
that visually color tablets of formula 1 to 5 
are increasingly off-white, it is because the 
contents of sodium alginate are increasing. 
Sodium alginate used in this study is a light 
brown. Surface shape and consistency of the 
tablet of formula 1 and formula 3 is smooth 
and compact, the formula 4 is rather rough 
and compact, and the formula 5 coarse and 
rather compact. Granule formula 5 in 
addition to having a larger size also has the 
ability to form a compact mass after a given 
pressure (compactibility) is relatively low so 
that when compressed by the same pressure 
with the other formulas produced tablets 
with slightly rough surface and rather 
compact (Ansel, 2005). 
 
Table 2. Experiment results 
No. Evaluation F1 F2 F3 F4 F5 
1. 
2. 
 
3. 
4. 
5. 
 
6. 
7. 
 
8. 
 
9. 
 
10. 
 
11. 
12. 
13. 
 
 
 
 
 
Baring angle (x°) 
Flow time 
(seconds) 
Colour 
Odor 
Surface shape 
 
Physical damage 
Thickness of 
Tablet (cm) 
Diametre of Tablet 
(cm) 
Average of weight 
uniformity (mg) 
Hardness of tablets 
(kg) 
Friability (%) 
DE480 (%) 
Release kinetics of 
captopril 
regression data 
a. Zero Order 
b. Higuchi 
c. First Order 
27,147±1,196 
2,283±0,112 
 
White 
Sulfida 
Smooth and 
compact 
No 
0,3970,005 
 
0,8100,000 
 
205,5 
 
7,650,474 
 
0,207 0,049 
74,957 
 
 
 
0,8503 
0,9074 
0,8447 
28,733±0,451 
2,237±0,032 
 
White 
Sulfida 
Smooth and 
compact 
No 
0,3880,008 
 
0,8100,000 
 
199,1 
 
7,800,587 
 
0,199 0,109 
56,039 
 
 
 
0,8442 
0,9663 
0,9628 
28,733±1,020 
2,267±0,232 
 
White 
Sulfida 
Smooth and 
compact 
No 
0,3440,007 
 
0,8100,000 
 
196,0 
 
8,850,530 
 
0,180 0,107 
51,226 
 
 
 
0,9025 
0,9842 
0,9317 
29,063±0,549 
2,137±0,130 
 
White 
Sulfida 
Rather rough 
and compact 
No 
0,4500,008 
 
0,8100,000 
 
205,7 
 
6,750,486 
 
0,396 0,071 
60,936 
 
 
 
0,9228 
0,9556 
0,8507 
27,967±0,333 
1,637±0,025 
 
White 
Sulfida 
Rough and 
rather compact 
No 
0,4210,008 
 
0,8100,000 
 
204,1 
 
4,600,516 
 
2,199 0,429 
52,066 
 
 
 
0,8484 
0,9256 
0,8893 
 
The results test of size uniformity showed 
that all tablets meet the test requirements of 
the physical properties of the uniformity of 
thickness and diametre size of the tablet 
because it is still within the permissible 
range of the diametre should be no more than 
three times as thick tablet and should not be 
less than one third of the tablet thickness 
(Anonymous, 1979). Based on this analysis 
it can be concluded that the tablets have been 
prepared to have a uniform size. Size 
uniformity of the tablets can be assumed that 
there is uniformity of content of captopril in 
tablets. 
All the weight uniformity test data 
showed that all of formula eligible weighting 
uniformity based on the Indonesian 
Pharmacopoeia Third Edition, because none 
of the tablets deviated from 7.5% and 15% of 
the average tablet weight (Anonymous, 
1979). Tablet weight is determined by filling 
a number of granules residing in the 
compression chamber and associated with 
the flow properties of granules. Tests on the 
uniformity of tablet weight is also done by 
calculating the CV (Coeffisient Variation) 
and the results showed that the weight of 
each tablet formula qualify, since there is no 
formula that has a CV value of more than 
5%. Tablet with a good weight uniformity 
can be assumed that the contents of the 
active substance in the tablet is also uniform, 
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so the therapeutic effect resulted identical 
(Voight, 1995). 
All formula meets the requirements of 
tablet hardness. Tablet hardness is 
determined by the compactibility and 
compressibility granule. Compactibility and 
compressibilty very important associated 
with the easily of granules to be compressed 
so as to produce a hard tablet. Granules that 
has a poor compressibility and 
compactibility will require high pressure to 
be compressed into tablets (Ansel, 2005). 
Results of ANOVA test obtained 0.000 
significance. Results of hardness test showed 
significant differences between the formula, 
except between formula 1 and formula 2. 
Friability more than 1% is usually 
considered as a tablet is not good
13
. All 
formula meets all requirements friability 
except the formula 5. Friability determined 
by the bound inter-granules and the influence 
of compactibility and compressibility 
granules. Results of ANOVA test obtained 
significance (0.001) < 0.05. Further tested 
LSD, obtained results that only the formula 
5, which differed significantly compared to 
other formulas. 
The results of floating test captopril 
tablets with alginate cross-link matrix, as 
shown in Figure 1, Figure 2, Figure 3, and 
Figure 4, respectively. 
 
Figure 1. Floating test 0 minute 
 
Figure 2. Floating test 180 minute 
 
Figure 3. Floating test 300 minute 
 
Figure 4. Floating test 1 day 
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At the beginning of the test, each tablet of 
the five formulas immediately float and 
gradually swell. During the 5-hour period, 
tablets still in the form and afloat with the 
swelling surface. Tablet floatation due to the 
selection of excipients that have a smaller 
density than water (Wikarsa and Valentina, 
2011). Crosslinking sodium alginate with 
calcium chloride aided with HPMC K4M 
produces matrix strong enough to maintain 
the integrity of the tablet during the floating 
test. When the tablet in contact with the 
medium, ac-in-sol which serves as 
disintegran and sodium alginate which have 
swelling properties will form pores in the 
layer of HPMC K4M so that the tablet 
directly to float and then HPMC K4M 
hydrated then tablets can swell. 
Tablet attached to the wall surface of the 
beaker glass, this was due to sodium alginate 
has bioadhesive properties (Rowe et al, 
2006). After settling in period of 24 hours of 
tablet still afloat but the gel-like consistency 
was formed shortly after that the tablets is 
sinking. Tablets can float in the long term 
(more than 24 hours), because there is an 
excipient that has a small density and sodium 
alginate has bioadhesive properties so 
attached to the beaker glass walls and can 
withstand tablet still afloat. 
The maximum wavelength of captopril in 
the wavelength range between 197-250 nm 
and obtained the maximum wavelength is 
205 nm. USP 29 (2007) states that the 
maximum wavelength of captopril tablets is 
205 nm and the absorbance were relatively 
stable at HCl pH 1.2, this indicates that the 
maximum wavelength obtained in the 
experiment is in agreement with theory.  
Captopril standard curve obtained by 
making a series of captopril solution at pH 
1.2 in HCl medium, namely the 
concentration of 0.008;  0.010;  0.012;  
0.014;  0.016 mg/mL. Absorbance of each 
concentration was measured by UV-vis 
spectrophotometer at a wavelength of 205 
nm. Absorbance data obtained and graphed 
against the concentration to obtain the 
regression equation and curve. Data are 
presented in Figure 5. Drug release test 
performed using the method of dissolution 
testing. Dissolution profile with a slow-
release tablet captopril floating system using 
alginate cross-links matrix is presented in 
Figure 6. 
 
 
Figure 5. Curve of captopril solution standard 
 
 
y = 43x - 0,1554 
R² = 0,979 
y = 43x - 0,1554 
R² = 0,989 
A
b
so
rb
a
n
ce
 
Concentration  (mg/mL) 
Curve of captopril solution standard 
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Figure 6. Dissolution profiles of Captopril slow release tablet 
 
Based on Figure 6 drug release from 
slow-release tablet captopril floating system 
using a matrix of alginate cross-links with 
calcium chloride as the crosslinker has a 
slow-release effect, where in 8 hours of 
formula 1 are able to release the drug as 
much as 100% after hours-6; formula 2 able 
to release the drug as much as 72.199%; 
formula 3 is able to release the drug as much 
as 72.395%; formula 4 can release the drug 
as much as 91.385; and formula 5 can release 
the drug as much as 73.739%. Content 
variation of sodium alginate with calcium 
chloride can affect the release of the drug in 
dosage form. In addition to the observation 
of drug release profile also calculated the 
value of dissolution efficiency (DE).  
Dissolution efficiency is the parameters 
that describe the ability of drug release from 
a preparation at a certain time. This method 
is a comparison of the area under the curve 
and the dissolution rate at the same time. 
Dissolution efficiency calculated by 
comparing area under the curve dissolution 
with the rectangular area 100% of active 
substances are dissolved at the certain time. 
DE method can be described the entire 
process of dissolution until at a certain time, 
so all points on the curve describing the 
dissolution. In addition disclosure DE 
method is identical to the disclosure of trial 
data in vivo (Khan and Rhodes, 1975). The 
area under the curve dissolution rate 
calculated based on the equation: 
 
Where     area under the curve at 
the time area between tn dan tn-1, ; Cn is the 
concentration of active substance dissolved 
at the time tn; Cn-1 is the concentration of 
active substance dissolved at the time tn-1
 
(Khan and Rhodes, 1975). 
Results of DE480 calculation showed that 
the variation of sodium alginate (10%) with 
calcium chloride (5%) is the formula 3 has 
the smallest value of DE480. This suggests 
that the cross-link formed will affect the 
release of drug from the dosage form. Cross-
link was formed lead to the molecular 
motion is restricted and inhibited the 
development of polymer in the medium 
(Kroschwitz et al, 1992) and with the help of 
HPMC K4M will form a solid matrix to hold 
the drug release.  
Drug release from slow-release 
preparations, ideally regardless constantly 
from start to finish or follow the model of 
zero-order kinetics (Ansel, 2005). Kinetics of 
release of captopril was determined by the 
equation: 
 
Zero Order : F = a1 + b1 . t  ....................... (1) 
First Order  : ln(100-%F) = a2 –b2 . t  ........ (2) 
Higuchi  : F = a3 + b3 . √t  ..................... (3) 
 
Where F is the amount of drug released at 
time t; a1, a2, a3 is intercept and b1, b2, b3 
C
a
p
to
p
ri
l 
d
is
so
lu
te
d
 (
%
) 
Time (Minutes) 
Dissolution profiles of Captopril slow release tablet 
F1
F2
F3
F4
F5
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are slope. Release kinetics of captopril was 
determined by direct regression of the 
amount of drug dissolved versus time (zero 
order), Wagner equation (first order) 
(Wagner, 1971) and Higuchi equations.  
The value of the correlation coefficients 
obtained can be concluded that the order of 
the reaction is more dominant in the kinetics 
of drug release is to follow the Higuchi 
kinetics equation. When the number of drug 
released from the matrix is proportional to 
the root of the time it is said to follow a zero-
order kinetics (Higuchi, 1963). 
If drug released controlled by the matix 
erosion so the correlation between the 
amount of drug released versus time is linear 
(Lipidus and Lordi, 1968). If the amount of 
drug released versus root of time is linear so 
controlled release by diffution matrix. Based 
on research results that showed the linearity 
of the correlation between the amount of 
drug released versus time and the amount of 
drug released versus root of time, the release 
mechanism of captopril cross-link matrix 
alginate with calcium chloride controlled 
both mechanism i.e diffution and erotion. 
Diffusion mechanisme is more dominant, it 
can be seen the value r for the equation of 
the curve captopril dissolved to the root of 
time closest to 1 compared to the time line 
captopril dissolved. 
The results showed that the formula 
captopril slow-release tablet with floating 
system using alginate cross-link matrix is 
able to maintain the release of captopril to 8 
hours and release mechanism follows zero 
order kinetics. The development of this 
formula can be done with the study of 
absorption in in vitro fertilization, i.e. by 
doing drug permeation studies, aiming as 
screening process against a potential cure for 
transfers orally. 
 
Conclusion 
Captopril sustained release tablets using a 
system of floating alginate matrix cross 
linkage with calcium chloride has physical 
characteristics that meet the general 
requirements for tablets (physical 
appearance, uniformity of size, uniformity of 
weight, hardness, and friability), except 
formula 5 which has friability 2.199%. 
Profile of drug release shows that the 
coherency matrix of alginate crosslinked 
with calcium chloride was able to keep the 
release of captopril to 8 hours, proven 
formula 2 which releases the drug at least 
72.199% with the release kinetics followed 
zero-order kinetics. The mechanism of 
release is a combination of erosion and 
diffusion. 
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